These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 32245084)

  • 1. High-Protein Diet Induces Hyperuricemia in a New Animal Model for Studying Human Gout.
    Hong F; Zheng A; Xu P; Wang J; Xue T; Dai S; Pan S; Guo Y; Xie X; Li L; Qiao X; Liu G; Zhai Y
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice.
    Liang G; Nie Y; Chang Y; Zeng S; Liang C; Zheng X; Xiao D; Zhan S; Zheng Q
    Phytomedicine; 2019 Jun; 59():152772. PubMed ID: 31005813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia and gout.
    German DC; Holmes EW
    Med Clin North Am; 1986 Mar; 70(2):419-36. PubMed ID: 3512932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis.
    Castrejon I; Toledano E; Rosario MP; Loza E; Pérez-Ruiz F; Carmona L
    Rheumatol Int; 2015 Jul; 35(7):1127-37. PubMed ID: 25519877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major unanswered questions in the clinical gout field.
    Stamp LK
    Curr Opin Rheumatol; 2017 Mar; 29(2):171-177. PubMed ID: 27926541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
    Perez-Ruiz F; Herrero-Beites AM; Carmona L
    Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rasburicase (Fasturtec)].
    Vogt B; Gugger M; Frey FJ
    Ther Umsch; 2004 Sep; 61(9):579-82. PubMed ID: 15493120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions.
    Torralba KD; De Jesus E; Rachabattula S
    Int J Rheum Dis; 2012 Dec; 15(6):499-506. PubMed ID: 23253231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Gout and Hyperuricemia in CKD.
    Vargas-Santos AB; Neogi T
    Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Gupta MK; Singh JA
    Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperuricemia and gout: diagnosis and therapy].
    Tausche AK; Unger S; Richter K; Wunderlich C; Grässler J; Roch B; Schröder HE
    Internist (Berl); 2006 May; 47(5):509-20; quiz 521. PubMed ID: 16586130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of Cytokines and MicroRNAs in Individuals With Asymptomatic Hyperuricemia and Ultrasonographic Findings of Gout: A Bench-to-Bedside Approach.
    Estevez-Garcia IO; Gallegos-Nava S; Vera-Pérez E; Silveira LH; Ventura-Ríos L; Vancini G; Hernández-Díaz C; Sánchez-Muñoz F; Ballinas-Verdugo MA; Gutierrez M; Pineda C; Rodriguez-Henriquez P; Castillo-Martínez D; Amezcua-Guerra LM
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1814-1821. PubMed ID: 29457379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.